Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 39

1.

Improving the safety of CAR-T cell therapy by controlling CRS-related coagulopathy.

Jiang H, Liu L, Guo T, Wu Y, Ai L, Deng J, Dong J, Mei H, Hu Y.

Ann Hematol. 2019 Jul;98(7):1721-1732. doi: 10.1007/s00277-019-03685-z. Epub 2019 May 4.

PMID:
31055613
2.

Stunting and Overweight among 12-24-Month-Old Children Receiving Vaccination in Ho Chi Minh City, Vietnam.

Giao H, Le An P, Truong Vien N, Van Khanh T, Quang Vinh B.

Biomed Res Int. 2019 Feb 19;2019:1547626. doi: 10.1155/2019/1547626. eCollection 2019.

3.

Introduction of a second MenB vaccine into Europe - needs and opportunities for public health.

Findlow J, Nuttens C, Kriz P.

Expert Rev Vaccines. 2019 Mar;18(3):225-239. doi: 10.1080/14760584.2019.1578217. Epub 2019 Mar 1. Review.

PMID:
30821535
4.

Determinants of delayed or incomplete diphtheria-tetanus-pertussis vaccination in parallel urban and rural birth cohorts of 30,956 infants in Tanzania.

Nadella P, Smith ER, Muhihi A, Noor RA, Masanja H, Fawzi WW, Sudfeld CR.

BMC Infect Dis. 2019 Feb 26;19(1):188. doi: 10.1186/s12879-019-3828-3.

5.

Oral Sucrose Versus Breastfeeding in Managing Infants' Immunization-Related Pain: A Randomized Controlled Trial.

Gad RF, Dowling DA, Abusaad FE, Bassiouny MR, Abd El Aziz MA.

MCN Am J Matern Child Nurs. 2019 Mar/Apr;44(2):108-114. doi: 10.1097/NMC.0000000000000512.

PMID:
30807328
6.

Clinical experience with the inactivated hepatitis A vaccine, Avaxim 80U Pediatric.

Bravo C, Mege L, Vigne C, Thollot Y.

Expert Rev Vaccines. 2019 Mar;18(3):209-223. doi: 10.1080/14760584.2019.1580578. Epub 2019 Feb 26. Review.

PMID:
30806110
7.

Indian Academy of Pediatrics (IAP) Advisory Committee on Vaccines and Immunization Practices (ACVIP) Recommended Immunization Schedule (2018-19) and Update on Immunization for Children Aged 0 Through 18 Years.

Balasubramanian S, Shah A, Pemde HK, Chatterjee P, Shivananda S, Guduru VK, Soans S, Shastri D, Kumar R; IAP Advisory Committee on Vaccines and Immunization Practices, 2018-19.

Indian Pediatr. 2018 Dec 15;55(12):1066-1074.

8.

Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger - United States, 2019.

Robinson CL, Bernstein H, Romero JR, Szilagyi P.

MMWR Morb Mortal Wkly Rep. 2019 Feb 8;68(5):112-114. doi: 10.15585/mmwr.mm6805a4.

9.

Promoting vaccination in the province of Québec: the PromoVaQ randomized controlled trial protocol.

Gagneur A, Quach C, Boucher FD, Tapiero B, De Wals P, Farrands A, Lemaitre T, Boulianne N, Sauvageau C, Ouakki M, Gosselin V, Gagnon D, Petit G, Jacques MC, Dubé È.

BMC Public Health. 2019 Feb 6;19(1):160. doi: 10.1186/s12889-019-6468-z.

10.

Immunizations.

Wilde BB, Park DJ.

Prim Care. 2019 Mar;46(1):53-68. doi: 10.1016/j.pop.2018.10.007. Epub 2018 Dec 22. Review.

PMID:
30704660
11.

[Alternative HPV vaccination schedules in Latin America].

Robles C, Hernández ML, Almonte M.

Salud Publica Mex. 2018 Nov-Dic;60(6):693-702. doi: 10.21149/9810. Review.

PMID:
30699274
12.

HPV vaccine implementation and monitoring in Latin America.

Luciani S, Bruni L, Agurto I, Ruiz-Matus C.

Salud Publica Mex. 2018 Nov-Dic;60(6):683-692. doi: 10.21149/9090. Review.

PMID:
30699273
13.

The effect of a booster dose of HPV tetravalent vaccine after 51 months: implications for extended vaccination schedules.

Lazcano-Ponce E, Carnalla-Cortés M, Barrientos-Gutiérrez T, Torres-Ibarra L, Cruz-Valdez A, Salmerón J, Hernández-Ávila M.

Salud Publica Mex. 2018 Nov-Dic;60(6):666-673. doi: 10.21149/10183.

PMID:
30699272
14.

Introducing new vaccines in low- and middle-income countries: challenges and approaches.

Guignard A, Praet N, Jusot V, Bakker M, Baril L.

Expert Rev Vaccines. 2019 Feb;18(2):119-131. doi: 10.1080/14760584.2019.1574224. Epub 2019 Feb 11. Review.

PMID:
30689472
15.

Effective HPV Vaccination Strategies: What Does the Evidence Say? An Integrated Literature Review.

Holloway GL.

J Pediatr Nurs. 2019 Jan - Feb;44:31-41. doi: 10.1016/j.pedn.2018.10.006. Epub 2018 Oct 24. Review.

PMID:
30683279
16.

Is There a Resurgence of Vaccine Preventable Diseases in the U.S.?

Kubin L.

J Pediatr Nurs. 2019 Jan - Feb;44:115-118. doi: 10.1016/j.pedn.2018.11.011. Epub 2018 Nov 29. Review.

PMID:
30683276
17.

Aiming at the heart: the capsid protein of dengue virus as a vaccine candidate.

Lazo L, Valdes I, Guillén G, Hermida L, Gil L.

Expert Rev Vaccines. 2019 Feb;18(2):161-173. doi: 10.1080/14760584.2019.1574575. Epub 2019 Feb 11. Review.

PMID:
30677305
18.

Eradication of human papillomavirus and elimination of HPV-related diseases - scientific basis for global public health policies.

Lehtinen M, Baussano I, Paavonen J, Vänskä S, Dillner J.

Expert Rev Vaccines. 2019 Feb;18(2):153-160. doi: 10.1080/14760584.2019.1568876. Epub 2019 Feb 7. Review.

PMID:
30657348
19.

Rationale for the Immunization Schedule: Why Is It the Way It Is?

Shetty VU, Chaudhuri P, Sabella C.

Pediatr Rev. 2019 Jan;40(1):26-36. doi: 10.1542/pir.2018-0033. Review. No abstract available.

PMID:
30600276
20.

Current landscape of nonmedical vaccination exemptions in the United States: impact of policy changes.

Bednarczyk RA, King AR, Lahijani A, Omer SB.

Expert Rev Vaccines. 2019 Feb;18(2):175-190. doi: 10.1080/14760584.2019.1562344. Epub 2019 Jan 4. Review.

PMID:
30572729

Supplemental Content

Loading ...
Support Center